Immunosuppressive Agents: all 5,940 studies that test it

Page 11 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple MyelomaCompletedNCT02597062Phase 2Results posted
• A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)CompletedNCT02596971Phase 1/2Results posted
• Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisCompletedNCT02595398Phase 3Results posted
• Abatacept in Juvenile DermatomyositisCompletedNCT02594735Phase 4Results posted
• Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)CompletedNCT02592798Phase 2Results posted
• Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid LeukemiaCompletedNCT02583893Phase 2Results posted
• Reduced Intensity Conditioning Transplant Using Haploidentical DonorsCompletedNCT02581007Phase 2Results posted
• A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)CompletedNCT02576145Phase 4Results posted
• Cardiovascular Inflammation Reduction Trial - Inflammation Imaging StudyCompletedNCT02576067Phase 3Results posted
• Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaActive, not recruitingNCT02567435Phase 3Results posted
• Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02566304Phase 2Results posted
• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02565901Phase 1/2Results posted
• Bela 8 Week DosingCompletedNCT02560558Phase 4Results posted
• Personalized Targeted Inhibitors Treatment in Renal Cell CancerTerminatedNCT02560012Phase 2Results posted
• Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid ArthritisCompletedNCT02557100Phase 4Results posted
• Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft MalignanciesCompletedNCT02556931Phase 2Results posted
• Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT02555215Phase 3Results posted
• Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®CompletedNCT02554981Phase 4Results posted
• Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) IActive, not recruitingNCT02553460Phase 1/2Results posted
• Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASCompletedNCT02552212Phase 3Results posted
• A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL AmyloidosisCompletedNCT02545907Phase 1/2Results posted
• A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver TransplantationCompletedNCT02544113Phase 2Results posted
• A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple MyelomaCompletedNCT02541383Phase 3Results posted
• Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on EverolimusTerminatedNCT02539459Phase 2Results posted
• A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)CompletedNCT02533401Phase 2Results posted
• Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).CompletedNCT02525874Phase 3Results posted
• Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of AntibioticsCompletedNCT02525523Phase 3Results posted
• Granulation Tissue Treatment: Silver Nitrate vs Kenalog vs Washcloth AbrasionTerminatedNCT02519738Phase 3Results posted
• Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula OutcomesCompletedNCT02513303Phase 3Results posted
• Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood CellsTerminatedNCT02512679Phase 2Results posted
• Leflunomide in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT02509052Phase 1/2Results posted
• Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpACompletedNCT02509026Phase 4Results posted
• Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165CompletedNCT02507336Phase 2Results posted
• Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to PlaceboCompletedNCT02505542Phase 3Results posted
• Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal CancerTerminatedNCT02504892Phase 2Results posted
• Effects of Abatacept in Patients With Early Rheumatoid ArthritisCompletedNCT02504268Phase 3Results posted
• Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial CystitisCompletedNCT02497976Phase 3Results posted
• Examining the Impact of Sirolimus on Ketamine's Antidepressant EffectsCompletedNCT02487485Phase 2Results posted
• A Long Term Safety Extension Study (CHS-0214-05)CompletedNCT02486939Phase 3Results posted
• Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the KneeTerminatedNCT02468583Phase 2Results posted
• Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal TransplantCompletedNCT02464878Phase 2Results posted
• EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 DiabetesCompletedNCT02464033Phase 2Results posted
• Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot InitiativeCompletedNCT02456857Phase 2Results posted
• Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)CompletedNCT02454478Phase 1Results posted
• IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIACompletedNCT02451748Phase 4Results posted
• A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCDCompletedNCT02451696Phase 2Results posted
• A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant RecipientsCompletedNCT02444143Phase 4Results posted
• Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)CompletedNCT02440789Phase 1/2Results posted
• Dimethyl Fumarate for Obstructive Sleep ApneaCompletedNCT02438137Phase 2Results posted
• Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger PatientsTerminatedNCT02433483Phase 2Results posted
• BG00012 and Delay of Disability Progression in Secondary Progressive Multiple SclerosisTerminatedNCT02430532Phase 3Results posted
• Abatacept for SLE Arthritis (IM101-330)TerminatedNCT02429934Phase 1/2Results posted
• Impact of Everolimus on HIV Persistence Post Kidney or Liver TransplantCompletedNCT02429869Phase 4Results posted
• Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K ActivationCompletedNCT02428296Phase 2Results posted
• Tecfidera Slow-Titration StudyTerminatedNCT02428231Phase 3Results posted
• Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of MelanomaTerminatedNCT02425306Phase 1/2Results posted
• Optimising Renal Outcome in Myeloma Renal FailureCompletedNCT02424851Phase 2Results posted
• Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment RegimenCompletedNCT02419742Phase 4Results posted
• Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast CancerCompletedNCT02413320Phase 2Results posted
• Evaluate if Response to Infliximab or Adalimumab May be Regained With an ImmunomodulatorTerminatedNCT02413047Not applicableResults posted
• Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract CancerCompletedNCT02412670Phase 2Results posted
• Ixazomib, Cyclophosphamide and Dexamethasone for Multiple MyelomaCompletedNCT02412228Phase 2Results posted
• Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMSCompletedNCT02410200Phase 2Results posted
• Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or MesotheliomaTerminatedNCT02408016Phase 1/2Results posted
• Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) SubjectsCompletedNCT02404025Phase 2Results posted
• Fasting on Newly Diagnosed Breast CancerTerminatedNCT02379585Phase 1/2Results posted
• Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis SubjectsCompletedNCT02378506Phase 3Results posted
• Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisCompletedNCT02376790Phase 3Results posted
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema TrialCompletedNCT02374060Phase 3Results posted
• Treatments Against RA and Effect on FDG-PET/CTCompletedNCT02374021Phase 4Results posted
• Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionCompletedNCT02373813Phase 3Results posted
• Fingolimod Effect on Cytokine and Chemokine LevelsCompletedNCT02373098Phase 4Results posted
• DC Migration Study for Newly-Diagnosed GBMCompletedNCT02366728Phase 2Results posted
• Inflammation and Coronary Endothelial FunctionCompletedNCT02366091Phase 2Results posted
• GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell TransplantTerminatedNCT02360111Not applicableResults posted
• Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the KneeCompletedNCT02357459Phase 3Results posted
• Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMDCompletedNCT02357342Phase 2Results posted
• Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or AbataceptTerminatedNCT02353780Phase 4Results posted
• Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 MutationsCompletedNCT02352844Phase 2Results posted
• Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCTTerminatedNCT02349178Phase 2Results posted
• Belimumab in Idiopathic Inflammatory MyositisCompletedNCT02347891Phase 2/3Results posted
• Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)CompletedNCT02346240Phase 3Results posted
• Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)CompletedNCT02345850Phase 3Results posted
• Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.TerminatedNCT02343159Phase 4Results posted
• Pharmacokinetic Comparison Of All FK-506 FormulationsCompletedNCT02339246Phase 3Results posted
• Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With EverolimusCompletedNCT02338609Phase 4Results posted
• Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232TCompletedNCT02332902Phase 2Results posted
• Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen PlanusCompletedNCT02329600Phase 3Results posted
• New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System InvolvementCompletedNCT02329080Phase 2Results posted
• Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid LeukemiaCompletedNCT02328755Phase 1/2Results posted
• Belatacept Conversion in Proteinuric Kidney Transplant RecipientsCompletedNCT02327403Phase 2Results posted
• An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326298Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326272Phase 3Results posted
• An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044CompletedNCT02319642Phase 3Results posted
• Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).CompletedNCT02318667Phase 4Results posted
• Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive SurgeryTerminatedNCT02315625Phase 2Results posted
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)CompletedNCT02314403Phase 1Results posted
• A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDsCompletedNCT02308163Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) TreatmentCompletedNCT02305849Phase 3Results posted
• A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)CompletedNCT02293902Phase 3Results posted

← Immunosuppressive Agents overview